Objective: To determine the influence of methylprednisolone on the cytokine
balance during cardiac surgery.
Design: Prospective, randomized, nonblinded study.
Setting: University hospital.
Patients: Twenty-one patients on cardiopulmonary bypass undergoing aortocor
onary bypass surgery.
Interventions: According to a randomized sequence, the patients either rece
ived methylprednisolone (30 mu g/kg) before cardiopulmonary bypass and befo
re declamping of the aorta (MPS group, n = 11)or received nothing (control
group, n = 10).
Measurements and Main Results: Serum proinflammatory cytokines (interleukin
[IL]-8, IL-6) and anti-inflammatory cytokines (IL-10, IL-1ra) were measure
d by enzyme-linked immunosorbent assays. Serum IL-6 and IL-8 concentrations
in the control group (15.2 +/- 4.1 and 14.1 +/- 1.9 pg/mL, preoperatively)
increased to 242 +/- 70.1 and 97.3 +/- 18.3 pg/mL at 60 mins after declamp
ing of the aorta (p < .01, p < .01, respectively). The increases were great
er than those from 2.5 +/- 0.6 and 2.5 +/- 0.5 pg/mL to 109.5 +/- 29.0 and
33 +/- 4.1 pg/mL in the MPS group for IL-6 and IL-8, respectively. Serum IL
10 concentrations increased significantly 60 mins after declamping of the
aorta compared with its preoperative value in the two groups (the control g
roup, from 1.0 +/- 0 to 537.9 +/- 61.7 pg/mL; the MPS group, from 0.3 +/- 0
.2 to 654.9 +/- 24 pg/mL [p < .01, p < .01, respectively]). No difference w
as found between the two groups. Similarly, serum IL-1ra concentrations in
the two groups increased the preoperative value in the control group from 3
04 +/- 120 to 44,374 +/- 14,631 pg/mL and in the MPS group from 616.5 +/- 1
09.6 to 35,598 +/- 9,074 pg/mL at 60 mins after declamping of the aorta (p
< .01, p < .01, respectively). There was no difference between the two grou
ps.
Conclusions: Methylprednisolone reduces the production of IL-6 and IL-8 but
not that of IL-10 and IL-l ra. These results suggest that one of the mecha
nisms of the cytoprotective effect of methylprednisolone may be to make cha
nges in the proinflammatory and anti-inflammatory cytokine balance.